Vistagen TherapeuticsVTGN
13F holders, Q1 2024 (March 31)1holders
$5.28avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Vistagen Therapeutics Inc. (VTGN) in their 13F filings. The largest holder was TCG Crossover Management, LLC ($14.1M).
- Company
- Vistagen Therapeutics Inc.
- CUSIP
- 92840H202
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| TCG Crossover Management, LLC | 1.12% | No change | 2,676,580 | $14.1M |
"% of holder's portfolio" is VTGN's weight in each manager's 13F, not the share of Vistagen Therapeutics Inc. the manager owns.